Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients
Fbs. Oei et al., Circulating donor-specific cytotoxic T lymphocytes with high avidity for donor human leukocyte antigens in pediatric and adult cardiac allograft valved conduit recipients, EUR J CAR-T, 18(4), 2000, pp. 466-472
Objective: Specific immunological responses may be involved in the process
of cryopreserved allograft valved conduit (AVC) degeneration, which is more
frequently seen in young recipients. Rejection of heart and corneal allogr
afts is preceded by an increase in the fraction of cytotoxic T lymphocytes
(CTL) with high avidity for donor human leukocyte antigens (HLA) circulatin
g in both peripheral blood and the affected graft. These donor-specific hig
h-avidity CTLs are regarded as the destructive cells capable of causing gra
ft damage. To monitor the precursors of these cells (CTLp) in young and adu
lt AVC recipients, in vitro quantitative tests were performed on sequential
ly taken blood samples to quantitate CTLp frequencies and their avidity for
donor antigens. Method: Six children and nine adults who received a cryopr
eserved AVC in the period between 1994 and 1997 were included in the study.
From these patients, two to six blood samples were obtained up to 3 years
after valve implantation. The number of circulating CTLp present within the
peripheral blood mononuclear cell (PBMC) population was determined by limi
ting dilution analysis (LDA). The fraction of CTLp with high avidity for do
nor HLA class I was determined by addition of CD8 monoclonal antibodies (mA
b) during the cytotoxic phase of the assay. Third-party stimulator cells we
re used to verify the donor-specificity of the response. Results: The numbe
r of donor-specific CTLp increased significantly in the period 6-12 months
after AVC implantation, while third-party-specific CTLp frequencies were no
t affected. Additionally, we found a significant increase of the high-avidi
ty fraction of CTLp directed against donor antigens as early as during the
first 6 months after AVC implantation. The fraction of high-avidity CTLp re
mained significantly higher post- compared with pre-implantation, even afte
r 12 months. We observed no significant difference in the kinetics of CTLp
frequencies between pediatric and adult AVC recipients. Conclusion: Implant
ation of cryopreserved human AVC induces an increase in the total number of
circulating CTLp directed against donor HLA class I in both adults and chi
ldren. The shift towards more destructive high-avidity CTLp in the peripher
al blood indicates their potential damaging effect towards the heart valve
allograft. (C) 2000 Elsevier Science B.V. All rights reserved.